821 |
Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic ResponseSystems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response
Nikhil Kirtipal, Youngchang Seo, Jangwon Son, Sunjae LeeNikhil Kirtipal, Youngchang Seo, Jangwon Son, Sunjae Lee
KMSID: 1516088737 Diabetes Metab J. 2024;48(5):821-836. Published online 2024 September 12 DOI: http://dx.doi.org/10.4093/dmj.2024.0382 |
|
837 |
Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes MellitusBenefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
Ja Young Jeon, Dae Jung KimJa Young Jeon, Dae Jung Kim
KMSID: 1516088735 Diabetes Metab J. 2024;48(5):837-846. Published online 2024 September 12 DOI: http://dx.doi.org/10.4093/dmj.2024.0317 |
|
847 |
Artificial Light at Night and Type 2 Diabetes MellitusArtificial Light at Night and Type 2 Diabetes Mellitus
Jong-Ha Baek, Yong Zhu, Chandra L. Jackson, Yong-Moon Mark ParkJong-Ha Baek, Yong Zhu, Chandra L. Jackson, Yong-Moon Mark Park
KMSID: 1516088734 Diabetes Metab J. 2024;48(5):847-863. Published online 2024 September 12 DOI: http://dx.doi.org/10.4093/dmj.2024.0237 |
|
864 |
T-Cell Senescence in Human Metabolic DiseasesT-Cell Senescence in Human Metabolic Diseases
Ha Thi Nga, Thi Linh Nguyen, Hyon-Seung YiHa Thi Nga, Thi Linh Nguyen, Hyon-Seung Yi
KMSID: 1516088733 Diabetes Metab J. 2024;48(5):864-881. Published online 2024 August 28 DOI: http://dx.doi.org/10.4093/dmj.2024.0140 |
|
882 |
Ideal Combination of Oral Hypoglycemic Agents for Patients with Type 2 Diabetes MellitusIdeal Combination of Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus
Hye Soon KimHye Soon Kim
KMSID: 1516088731 Diabetes Metab J. 2024;48(5):882-884. Published online 2024 September 12 DOI: http://dx.doi.org/10.4093/dmj.2024.0479 |
|
885 |
Single-Cell Landscape and a Macrophage Subset Enhancing Brown Adipocyte Function in DiabetesSingle-Cell Landscape and a Macrophage Subset Enhancing Brown Adipocyte Function in Diabetes
Junfei Gu, Jiajia Jin, Xiaoyu Ren, Xinjie Zhang, Jiaxuan Li, Xiaowei Wang, Shucui Zhang, Xianlun Yin, Qunye Zhang, Zhe WangJunfei Gu, Jiajia Jin, Xiaoyu Ren, Xinjie Zhang, Jiaxuan Li, Xiaowei Wang, Shucui Zhang, Xianlun Yin, Qunye Zhang, Zhe Wang
KMSID: 1516088720 Diabetes Metab J. 2024;48(5):885-900. Published online 2024 May 29 DOI: http://dx.doi.org/10.4093/dmj.2023.0278 |
|
901 |
DGAT2 Plays a Crucial Role to Control ESRRAPROX1 Transcriptional Network to Maintain Hepatic Mitochondrial SustainabilityDGAT2 Plays a Crucial Role to Control ESRRAPROX1 Transcriptional Network to Maintain Hepatic Mitochondrial Sustainability
Yoseob Lee, Yeseong Hwang, Minki Kim, Hyeonuk Jeon, Seyeon Joo, Sungsoon Fang, Jae-Woo KimYoseob Lee, Yeseong Hwang, Minki Kim, Hyeonuk Jeon, Seyeon Joo, Sungsoon Fang, Jae-Woo Kim
KMSID: 1516088723 Diabetes Metab J. 2024;48(5):901-914. Published online 2024 April 22 DOI: http://dx.doi.org/10.4093/dmj.2023.0368 |
|
915 |
Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized TrialEfficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial
Ji-Yeon Park, Joonyub Lee, Yoon-Hee Choi, Kyung Wan Min, Kyung Ah Han, Kyu Jeung Ahn, Soo Lim, Young-Hyun Kim, Chul Woo Ahn, Kyung Mook Choi, Kun-Ho YoonJi-Yeon Park, Joonyub Lee, Yoon-Hee Choi, Kyung Wan Min, Kyung Ah Han, Kyu Jeung Ahn, Soo Lim, Young-Hyun Kim, Chul Woo Ahn, Kyung Mook Choi, Kun-Ho Yoon
KMSID: 1516088718 Diabetes Metab J. 2024;48(5):915-928. Published online 2024 April 23 DOI: http://dx.doi.org/10.4093/dmj.2023.0259 |
|
929 |
Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes MellitusEfficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus
Shinae Kang, Yu-Bae Ahn, Tae Keun Oh, Won-Young Lee, Sung Wan Chun, Boram Bae, Amine Dahaoui, Jin Sook Jeong, Sungeun Jung, Hak Chul JangShinae Kang, Yu-Bae Ahn, Tae Keun Oh, Won-Young Lee, Sung Wan Chun, Boram Bae, Amine Dahaoui, Jin Sook Jeong, Sungeun Jung, Hak Chul Jang
KMSID: 1516088719 Diabetes Metab J. 2024;48(5):929-936. Published online 2024 February 27 DOI: http://dx.doi.org/10.4093/dmj.2023.0297 |
|
937 |
Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled TrialPioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial
Ji Hye Heo, Kyung Ah Han, Jun Hwa Hong, Hyun-Ae Seo, Eun-Gyoung Hong, Jae Myung Yu, Hye Seung Jung, Bong-Soo ChaJi Hye Heo, Kyung Ah Han, Jun Hwa Hong, Hyun-Ae Seo, Eun-Gyoung Hong, Jae Myung Yu, Hye Seung Jung, Bong-Soo Cha
KMSID: 1516088722 Diabetes Metab J. 2024;48(5):937-948. Published online 2024 February 2 DOI: http://dx.doi.org/10.4093/dmj.2023.0314 |
|
949 |
A New Tool to Identify Pediatric Patients with Atypical Diabetes Associated with Gene PolymorphismsA New Tool to Identify Pediatric Patients with Atypical Diabetes Associated with Gene Polymorphisms
Sophie Welsch, Antoine Harvengt, Paola Gallo, Manon Martin, Dominique Beckers, Thierry Mouraux, Nicole Seret, Marie-Christine Lebrethon, Raphaël Helaers, Pascal Brouillard, Miikka Vikkula, Philippe A. LysySophie Welsch, Antoine Harvengt, Paola Gallo, Manon Martin, Dominique Beckers, Thierry Mouraux, Nicole Seret, Marie-Christine Lebrethon, Raphaël Helaers, Pascal Brouillard, Miikka Vikkula, Philippe A. Lysy
KMSID: 1516088717 Diabetes Metab J. 2024;48(5):949-959. Published online 2024 March 22 DOI: http://dx.doi.org/10.4093/dmj.2023.0166 |
|
960 |
Biologically Informed Polygenic Scores for Brain Insulin Receptor Network Are Associated with Cardiometabolic Risk Markers and Diabetes in WomenBiologically Informed Polygenic Scores for Brain Insulin Receptor Network Are Associated with Cardiometabolic Risk Markers and Diabetes in Women
Jannica S. Selenius, Patricia P. Silveira, Mikaela von Bonsdorff, Jari Lahti, Hannu Koistinen, Riitta Koistinen, Markku Seppälä, Johan G. Eriksson, Niko S. WaseniusJannica S. Selenius, Patricia P. Silveira, Mikaela von Bonsdorff, Jari Lahti, Hannu Koistinen, Riitta Koistinen, Markku Seppälä, Johan G. Eriksson, Niko S. Wasenius
KMSID: 1516088714 Diabetes Metab J. 2024;48(5):960-970. Published online 2024 March 25 DOI: http://dx.doi.org/10.4093/dmj.2023.0039 |
|
971 |
Healthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort StudyHealthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort Study
Qing Chang, Yixiao Zhang, Tingjing Zhang, Zuyun Liu, Limin Cao, Qing Zhang, Li Liu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Yang Ding, Yuhong Zhao, Kaijun Niu, Yang XiaQing Chang, Yixiao Zhang, Tingjing Zhang, Zuyun Liu, Limin Cao, Qing Zhang, Li Liu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Yang Ding, Yuhong Zhao, Kaijun Niu, Yang Xia
KMSID: 1516088715 Diabetes Metab J. 2024;48(5):971-982. Published online 2024 March 19 DOI: http://dx.doi.org/10.4093/dmj.2023.0133 |
|
983 |
Glycemic Control and Retinal Microvascular Changes in Type 2 Diabetes Mellitus Patients without Clinical RetinopathyGlycemic Control and Retinal Microvascular Changes in Type 2 Diabetes Mellitus Patients without Clinical Retinopathy
Kangmin Lee, Ga Hye Lee, Seung Eun Lee, Jee Myung Yang, Kunho BaeKangmin Lee, Ga Hye Lee, Seung Eun Lee, Jee Myung Yang, Kunho Bae
KMSID: 1516088716 Diabetes Metab J. 2024;48(5):983-992. Published online 2024 March 13 DOI: http://dx.doi.org/10.4093/dmj.2023.0149 |
|
993 |
Prognostic Value of Plasma Endothelin-1 in Predicting Worse Outcomes in Patients with Prediabetes and Diabetes and Stable Coronary Artery DiseasesPrognostic Value of Plasma Endothelin-1 in Predicting Worse Outcomes in Patients with Prediabetes and Diabetes and Stable Coronary Artery Diseases
Cheng Yang, Cheng-Gang Zhu, Yuan-Lin Guo, Na-Qiong Wu, Qian Dong, Rui-Xia Xu, Yong-Jian Wu, Jie Qian, Jian-Jun LiCheng Yang, Cheng-Gang Zhu, Yuan-Lin Guo, Na-Qiong Wu, Qian Dong, Rui-Xia Xu, Yong-Jian Wu, Jie Qian, Jian-Jun Li
KMSID: 1516088721 Diabetes Metab J. 2024;48(5):993-1002. Published online 2024 August 21 DOI: http://dx.doi.org/10.4093/dmj.2023.0410 |
|
1003 |
Construction of Risk Prediction Model of Type 2 Diabetic Kidney Disease Based on Deep Learning (Diabetes Metab J 2024;48:771-9)Construction of Risk Prediction Model of Type 2 Diabetic Kidney Disease Based on Deep Learning (Diabetes Metab J 2024;48:771-9)
Bo Mi Seo, Jong Wook ChoiBo Mi Seo, Jong Wook Choi
KMSID: 1516088730 Diabetes Metab J. 2024;48(5):1003-1004. Published online 2024 September 12 DOI: http://dx.doi.org/10.4093/dmj.2024.0464 |
|
1005 |
Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)
Eun Young LeeEun Young Lee
KMSID: 1516088736 Diabetes Metab J. 2024;48(5):1005-1007. Published online 2024 September 12 DOI: http://dx.doi.org/10.4093/dmj.2024.0417 |
|
1008 |
Construction of Risk Prediction Model of Type 2 Diabetic Kidney Disease Based on Deep Learning (Diabetes Metab J 2024;48:771-9)Construction of Risk Prediction Model of Type 2 Diabetic Kidney Disease Based on Deep Learning (Diabetes Metab J 2024;48:771-9)
Chuan Yun, Fangli Tang, Qingqing LouChuan Yun, Fangli Tang, Qingqing Lou
KMSID: 1516088732 Diabetes Metab J. 2024;48(5):1008-1011. Published online 2024 September 12 DOI: http://dx.doi.org/10.4093/dmj.2024.0490 |
|
1012 |
Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)
Young-Hwan Park, Minji Sohn, Soo LimYoung-Hwan Park, Minji Sohn, Soo Lim
KMSID: 1516088738 Diabetes Metab J. 2024;48(5):1012-1013. Published online 2024 September 12 DOI: http://dx.doi.org/10.4093/dmj.2024.0485 |
|